Navigation Links
Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement
Date:12/15/2009

NEW YORK, Dec. 15 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement

http://www.reportlinker.com/p0168104/The-Future-of-Orphan-Diseases-Therapeutics---Market-Forecasts-to-2015-Pipeline-Analysis-and-Reimbursement.html

Summary

The author has released its latest research "The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement" The report provides in-depth analysis of unmet needs, drivers and barriers that impact the global orphan diseases therapeutics market. The report analyzes the markets for orphan diseases therapeutics in the US, the top five countries in Europe (the UK, Germany, France, Italy and Spain) and Japan. Treatment usage patterns, sales, and price are forecast until 2015 for the key geographies as well as select therapeutic segments. Further, the report provides competitive benchmarking for the leading companies and also analyzes the mergers, acquisitions and licensing agreements that shape the global markets.

Th
'/>"/>

SOURCE Reportlinker
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related biology technology :

1. Reportlinker Adds Biotechnology Instrumentation - International Market Trends
2. Reportlinker Adds Microplate Instrumentation & Supplies - A Global Market Perspective
3. Reportlinker Adds Pharmacodynamic Assays
4. Reportlinker Adds Neurostimulation - A Global Market Perspective
5. Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective
6. Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities
7. Reportlinker Adds Chromium - Global Market Trends
8. Reportlinker Adds Industrial Enzymes - A Global Market Report
9. Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment
10. Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013
11. Reportlinker Adds Biotechnology Reagents - A Global Market Perspective
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... , May 17, 2013 /PRNewswire-iReach/ -- Aridis is ... reached with Switzerland -based Kenta ... human monoclonal antibody (mAb) products, and technologies. This ... products for treatment of infections by common pathogens ... aureus , Pseudomonas aeruginosa , Acinetobacter ...
(Date:5/17/2013)... The paradigm of ‘one drug, one target’ has ... predict the adverse and therapeutic effects of a drug. ... Biology at the Genomics Laboratory, Covance, will discuss the ... when used as part of the QC process. Additionally, ... to identify key clinical targets even in complex data ...
(Date:5/17/2013)... Brea, CA (PRWEB) May 17, 2013 IAC ... DisperSol Technologies, a start up laboratory needing to set up ... be moving to a larger facility within a year’s time. ... the knowledge that the laboratory is temporary? What is efficient ... 4 Series modular workstations from IAC Industries. The planners at ...
(Date:5/16/2013)... May 16, 2013 ISPE ... A. Myers, CAE, to the newly created position ... new role, Myers will be responsible for stimulating ... production strategies, advancing the Society’s Member-led and staff-driven ... continuing to refine organizational, membership and product marketing. ...
Breaking Biology Technology:Aridis Pharmaceuticals Announces Acquisition of Monoclonal Antibody Products and Technologies From Kenta Biotech 2Aridis Pharmaceuticals Announces Acquisition of Monoclonal Antibody Products and Technologies From Kenta Biotech 3New Downloadable Success Story: “How To Outfit a Dynamic Lab in Flux” 2ISPE Names Barbara A. Myers, CAE, as Vice President of Professional Development 2
... CUR ) today reported financial results for the three ... ), For the second quarter of 2008, the ... share, compared to a net loss of $1,798,911 or,$(0.06) ... attributable to,common stockholders for the first six months of ...
... Aug. 14 /Xinhua-PRNewswire-FirstCall/ --,China-Biotics, Inc. (OTC Bulletin Board: ... in the manufacture,research, development, marketing and distribution of ... first quarter of its 2009,fiscal year, ended June ... -- Net sales increased 19.5% year-over-year to ...
... Board: KDUS) announced today financial results for the second,quarter ended ... quarter of 2008 and for the same period,in 2007. Net ... to,net income of $218,960 for the same period in 2007. ... was $0.00, compared to basic net,income per share for the ...
Cached Biology Technology:Neuralstem Reports Second Quarter Financial Results and Highlights 2Neuralstem Reports Second Quarter Financial Results and Highlights 3Neuralstem Reports Second Quarter Financial Results and Highlights 4Neuralstem Reports Second Quarter Financial Results and Highlights 5Neuralstem Reports Second Quarter Financial Results and Highlights 6China-Biotics, Inc. Reports First Quarter 2009 Financial Results 2China-Biotics, Inc. Reports First Quarter 2009 Financial Results 3China-Biotics, Inc. Reports First Quarter 2009 Financial Results 4China-Biotics, Inc. Reports First Quarter 2009 Financial Results 5China-Biotics, Inc. Reports First Quarter 2009 Financial Results 6China-Biotics, Inc. Reports First Quarter 2009 Financial Results 7China-Biotics, Inc. Reports First Quarter 2009 Financial Results 8China-Biotics, Inc. Reports First Quarter 2009 Financial Results 9China-Biotics, Inc. Reports First Quarter 2009 Financial Results 10China-Biotics, Inc. Reports First Quarter 2009 Financial Results 11Cadus Reports Second Quarter 2008 Results 2Cadus Reports Second Quarter 2008 Results 3Cadus Reports Second Quarter 2008 Results 4
(Date:5/16/2013)... endothelium, the cellular layer lining the body,s blood ... hundred nanometers in thickness, this super-tenuous structure routinely ... compression to create a unique and highly dynamic ... tissues from the body,s circulatory system. , It,s ... must be physically breached to enable immune ...
(Date:5/16/2013)... about 23 million years old give unprecedented insight ... one of the most species-rich groups among the ... Professor Bettina Reichenbacher from the Division of Paleontology ... Environmental Sciences at Ludwig-Maximilians-Universitaet (LMU) in Munich / ... fossils which they assign to the group of ...
(Date:5/16/2013)... of us don,t ponder our pulses outside of the gym. ... to monitor heart health. , Zhenan Bao, a professor of ... than a dollar bill and no wider than a postage ... on the wrist, is sensitive enough to help doctors detect ... day be used to continuously track heart health and provide ...
Breaking Biology News(10 mins):Endothelium, heal thyself 2Endothelium, heal thyself 3Endothelium, heal thyself 4Paleontology: The eloquence of the otoliths 2Paleontology: The eloquence of the otoliths 3Stanford engineers monitor heart health using paper-thin flexible 'skin' 2Stanford engineers monitor heart health using paper-thin flexible 'skin' 3
... WEST LAFAYETTE, Ind. - New research findings suggest that ... pulsed laser and tiny metallic "nanocages" might enable both ... system works by shining near-infrared laser pulses through the ... made of an alloy of gold and silver - ...
... University of Illinois study, omega-3 fatty acids may be good ... implications for treating male infertility. "In our experiment, we ... enzyme important in making docosahexaenoic acid (DHA). In the absence ... any misshaped sperm that can,t get where they need to ...
... The world,s largest antimony mine has become the world,s ... antimony -- an element whose environmental and biological properties ... emergent contaminant," said IU Bloomington Ph.D. student Faye Liu, ... attention to it." Used in small quantities, antimony ...
Cached Biology News:Ultrasensitive imaging method uses gold-silver 'nanocages' 2U of I study: Lack of omega-3 fatty acid linked to male infertility 2A different kind of mine disaster 2A different kind of mine disaster 3
...
MAb to HLA, Class II-DR+DP Dry Ice: No Preservative: NaN3 Availability When Not in Inventory: 14-21 Business Days...
... The Corning CellBIND surface is produced ... a more hydrophilic surface giving more consistent, ... yields. CellBIND enhances cell attachment and growth ... serum-free medium. • CellBIND may provide a ...
... suspension array system, 100-240 V, uses multiplex ... quantitative analysis of up to 100 proteins ... The suspension array is composed of up ... which may be conjugated with a unique ...
Biology Products: